2010
DOI: 10.1016/s1474-4422(10)70163-0
|View full text |Cite
|
Sign up to set email alerts
|

Effects of antihypertensive treatment after acute stroke in the Continue Or Stop post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
136
1
4

Year Published

2013
2013
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 227 publications
(142 citation statements)
references
References 31 publications
1
136
1
4
Order By: Relevance
“…6,[20][21][22][23][24] Enrolling patients in the prehospital phase may help to elucidate whether early BP management is beneficial in acute stroke. This is of particular interest in acute ICH, where the phenomenon of hematoma expansion, a well-known predictor of poor prognosis and mortality, 25 occurs most often within the first 3 hours from ICH onset.…”
Section: Relationship Of Prehospital Bp and Sbp On Ed Arrivalmentioning
confidence: 99%
“…6,[20][21][22][23][24] Enrolling patients in the prehospital phase may help to elucidate whether early BP management is beneficial in acute stroke. This is of particular interest in acute ICH, where the phenomenon of hematoma expansion, a well-known predictor of poor prognosis and mortality, 25 occurs most often within the first 3 hours from ICH onset.…”
Section: Relationship Of Prehospital Bp and Sbp On Ed Arrivalmentioning
confidence: 99%
“…The patients were randomly assigned to either continue or stop antihypertensive drugs. At two weeks, there was no significant difference between groups for the primary outcome of death or dependency; the difference between the 'continue' and 'stop' groups for systolic (13 mmHg) and diastolic (8 mmHg) blood pressure was significant [14].…”
Section: Blood Pressure Management In Patients Not Receiving Thrombolmentioning
confidence: 79%
“…Studies on the management of hypertension in ischemic stroke have arrived at conflicting conclusions and only a few randomized trials of blood pressure lowering in acute ischemic stroke have been published [11][12][13][14][15].…”
Section: Blood Pressure Management In Patients Not Receiving Thrombolmentioning
confidence: 99%
“…An extensive literature of BP control trials in the acute phase never showed any advantage of BP lowering 32, 33, 34, 35, 36. However, these studies included intravenous tissue plasminogen activator (t‐PA)‐treated patients, where the arterial status was not systematically monitored during the reperfusion therapy.…”
Section: Discussionmentioning
confidence: 99%